期刊文献+

噬血细胞性淋巴组织细胞增生症前瞻性研究 被引量:5

Prospective Study of Hemophagocytic Lymphohistiocytosis in Children
原文传递
导出
摘要 目的探讨儿童噬血细胞性淋巴组织细胞增生症(HLH)的临床特点及预后影响因素。方法2004年1月-2007年5月本院收治HLH患儿64例。男43例,女21例;中位年龄4岁3个月。除诊断所需检测项目外,化疗前常规行头部CT或MRI检测,行脑脊液生化及常规分类、爱泼斯坦病毒(EBV)、巨细胞病毒、单纯疱疹病毒、柯萨奇病毒、埃可病毒抗体水平检测;并定期监测上述指标以评估疗效,对所有HLH采用统一的免疫化疗方案。结果1.化疗2周后,1例死亡,4例于化疗后8周放弃治疗未评估疗效,余59例均临床有效,其中21例随后因各种原因放弃治疗,32例进入停药观察期,其中3例停药后1个月内复发。2.患儿64例中EBV相关HLH(EBV-HLH)患儿47例(73.4%),29例疗效差者中24例(82.7%)为EBV-HLH。3.有60例(93.8%)患儿中枢神经系统受累,且影像学改变先于临床症状的出现。结论1.该组研究中多数患儿更倾向于继发HLH诊断。2.EBV-HLH是我国儿童HLH的主要类型,也是重要的预后不良因素之一。3.HLH患儿中枢神经系统受累的发病率高,预后差,但通过早期积极的治疗是可逆的。4.对HLH患儿确诊后应常规行头颅MRI检查。 Objective To explore the clinical characteristics and influential factors on prognosis of hemophagocytic lymphohistiocytosis (HLH) in children. Methods Sixty - four children with HLH were registered in this study group from Jan. 2004 to May 2007. Of these, twenty - one cases were girls and 43 cases were boys ; the median age at diagnosis was 4 years and 3 months. Apart from items needed by the diagnosis, brain computer tomography (CT) or magnetic resonance imaging ( MRI), cerebrospinal fluid analysis and antibodies of Epstein - Barr virus (EBV), cytomegalovirus, herpes simplex virus, Coxsackie virus, echo virus were detested prior chemotherapy routinely. All examinations above mentioned were monitored regularly. All patients were adopted the same immunochemotherapy protocol. Results 1. One child died and 4 children gave up therapy in 8 weeks after therapy without assessment. The rest 59 children showed improvement, and of these 21 children gave up therapy later on because of various reasons. Thirty - two children were off - therapy, and among them 3 children relapsed in 1 month. 2. Altogether 47 children (73.4%) had EBV infection, also EBV associated HLH ( EBV - HLH). Among the 29 children with unfavourable result ( death and relapse), 24 children ( 82.7 % ) were EBV - HLH. 3. Altogether 60 children (93.8%) had central nervous system(CNS) involvement and neuroradiological changes precede clinical manifestations. Conclusions 1. Majority of children in this study were prone to be secondary. HLH. 2. EBV - HLH is the main type of the secondary HLH in our country, and also is one of critical unfavourable prognosis factors. 3. CNS involvement in HLH has a very high frequency and poor prognosis. But that nonetheless there is still hope to recover completely as long as proper chemotherapy treatment is applied at an early stage. 4. Now that brain MRI changes can precede neurological symptoms, all children should have a MRI performed routinely from diagnosis.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2009年第3期181-184,共4页 Journal of Applied Clinical Pediatrics
基金 北京市自然科学基金项目资助(7072026)
关键词 噬血细胞性淋巴组织细胞增生症 爱泼斯坦病毒 中枢神经系统 hemophagocytic lymphohistiocytosis Epstein- Barr virus central nervous system
  • 相关文献

参考文献16

  • 1Henter JI, Home A, Arico M, et al. HLH - 2004 : Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [ J ]. Pediatr Blood Cancer,2007,48 (2) : 124 - 131.
  • 2Rouphael NG, Talati NJ, Vaughan C, et al. Infections associated with haemophagocytic syndrome [ J ]. Lancet Infect Dis, 2007,7 ( 12 ) : 814 - 822.
  • 3Zur Stadt U, Beutel K, Kolberq S,et al. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: Molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A [ J]. Hum Mutat,2006,27( 1 ) :62 -68.
  • 4Ma KA, Frayer RW, Filipovieh AH,et al. Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis [ J ]. J Clin Invest,2006,116 ( 1 ) : 182 - 192.
  • 5Zur Stadt U, Schmidt S, Kasper B, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL)type -4 to chromosome 6q24 and identification of mutations in syntaxin 11 [ J ]. Hum Mol Genet, 2005,14 (6) :827 -834.
  • 6Trapani JA, Voskoboinik I. Infective, neoplastic, and homeostatic sequelae of the loss of perforin function in humans[ J]. Adv Exp Med Biol, 2007,601:235 -242.
  • 7Imashuku S. Advances in the management of hemophagocytic lymphohistiocytosis[ J]. lnt J Hematol,2000,72( 1 ) : 1 - 11.
  • 8Marc T, Marina C, Stephane B, et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: A single center report of 48 patients [ J ]. Pediatrics,2006,117 ( 4 ) : 743 - 750.
  • 9Gershburg E, Pagano JS. Epstein-Barr virus infections:Prospects for treatment [ J ]. J Antimicrobl Chemother, 2005,56 ( 2 ) : 277 - 281.
  • 10Kawashiri S, Nakamura H, Kawakami A,et al. Emergence of Epstein- Barr virus - associated haemophagocytic syndrome upon treatment of systemic lupus erythematosus [ J ]. Lupus,2006,15 ( 1 ) :51 - 53.

同被引文献27

  • 1Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis [ J ]. Semin Oncol, 1991,18 ( 1 ) :29 - 33.
  • 2Henter JI, Home A, Arieo M, et al. HLH - 2004 : Diagnostic and thera- peutic guidelines for hemophagoeytie lymphohistiocytosis [J]. Pediatr Blood Cancer,2007,48(2) :124 -131.
  • 3Chuang HC, Lay JD, Hsieh WC, et al. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein - Barr virus - associated T - cell lymphoma: Nuclear factor - kappa B pathway as a potential therapeutic target [ J]. Cancer Sci,2007,98 (9) : 1281 - 1287.
  • 4Imashuku S. Advances in the management of hemophagocytic lymphohistiocytosis[ J]. Int J Hemato1,2000,72( 1 ) : 1 - 11.
  • 5Janka G. Familial and acquired hemophagocytic lymphohistiocytosis[ J]. Eur J Pediatr,2007,166 (2) :95 - 109.
  • 6Rouphael NG, Talati NJ, Vaughan C, et al. Infections associated with haemophagocytic syndrome[ J]. Lancet Infect Dis, 2007,7 ( 12 ) : 814 - 822.
  • 7Janka G. Hemophagocytic syndromes [ J ]. Blood Rev, 2007,21 ( 5 ) : 245 - 253.
  • 8Kashiwagi Y, Kawashima H, Sato S, et al. Virological and immunological characteristics of fatal virus - associated haemophagocytic syndrome (VAHS) [ J ]. Microbiol Immunol,2007,51 ( 1 ) : 53 - 62.
  • 9Henter JI,Ehrnst A, Andersson J, et al. Familial hemophagocytic lymphohistiocytosis and viral infections [ J ]. Acta Paediatr, 1993,82 ( 4 ) : 369 - 372.
  • 10Imashuku S, Kuriyama K, Teramura T, et al. Requirement for etoposide in the treatment of Epstein - Barr virus - associated hemophagocytic lymphohistiocytosis [J]. J Clin Oncol,2001,19 (10) :2665 - 2673.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部